Unlock stock picks and a broker-level newsfeed that powers Wall Street.
15 Most Advanced Countries in Medicine

In This Article:

In this article, we take a look at the 15 most advanced countries in medicine. You can skip our detailed analysis of the healthcare industry and go directly to 5 Most Advanced Countries in Medicine

The recent pandemic was the best reflection of the advancements in the field of medicine. Vaccines were developed at a lightning-fast pace, with the first vaccine for Covid-19 approved for Emergency Use Authorization (EUA) only a year after the outbreak. 

It was developed by a joint effort of two of the most advanced pharmaceutical companies when it comes to R&D - Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX). The former is an American company while the latter is German.

Other top pharma companies include names like Cigna Corporation (NYSE:CI), Sanofi (NASDAQ:SNY), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN).

Due to the medicine industry’s role in the improvement of human well-being, it leads to GDP growth through labor productivity and personal spending. The correlation coefficients for this are demonstrable.  

The US, Switzerland and Norway are some of the most advanced countries when it comes to the field of medicine, with huge healthcare spending, numerous pharmaceutical companies and sophisticated academia.

Outlook

Medicine is one of the fastest growing fields in the world. It encompasses the pharmaceutical industry, medical schools and hospitals. The demand for healthcare is expected to increase due to a variety of factors, such as an aging population and advances in medical technology. 

According to the Pharma Outlook 2030 by KPMG, many trends are shaping the pharma industry for 2030. For instance, the free-for-service payment model is increasingly being challenged by the end-users, hospitals and insurance agencies. They want the pricing model to be designed around the success and the quality of the product. 

One of the most prominent results of this is Cigna Corporation (NYSE:CI)’s 2016 value-based contracts with Sanofi (NASDAQ:SNY), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN) for cholesterol drugs, with the insurance agencies receiving discounts if their therapies do not reduce cholesterol levels enough. 

Advances in big data and machine learning are also likely to allow for the pre-emptive measures against the onset of diseases instead of just treating them. Further, machine learning is also set to play a pivotal role in drug discovery.

A recent example is the AlphaFold, a deep learning model by Alphabet Inc. (NASDAQ:GOOG)’s subsidiary - DeepMind. It has solved 98.5% of human proteins’ structures, an important leap in drug discovery. Priorly, it had been a challenge that had puzzled molecular biologists for half a century.